PHAROS
Pharos Pharmaceuticals Inc. is engaged in research and development of proprietary therapeutic products for treatment of inflammatory and immunological diseases, with a goal to their commercialization in association with major pharmaceutical companies.
Pharos major asset is its US Patent 5,631,245 for Diosamine, a carbohydrate drug at pre-clinical stage of development. Diosamine is a non-specific immune modulator for therapeutic use that reverses inflammation and improper cell-mediated immunity. ENBDK, another discovery, is a precursor molecule of Diosamine where efficacy is highly dependent on the synthesis of the final compound by the organism of a healthy individual.
The business potential of Diosamine is as an oral drug for the treatment and prevention of inflammatory diseases and improper mediated immunity. The drug should restore to normal the proper functioning of a system in the human organism, treat a common factor of several diverse diseases and deal with hyper and improper inflammatory reactions affecting the immunological system. Its expected clinical uses are as differentiated topical drug for the treatment and prevention of hyper reactions to infectious diseases such as herpes; allergies and autoimmune disorders of the skin like psoriasis, eczema and scleroderma; and trauma related matters such as surgical incisions, ulcers, wounds, cosmetic surgery and burns.
Asset Management - DC&G provides the experience and competence found in larger firms to qualified high-net-worth individuals with the attention and expediency of a smaller enterprise.
Read more
Venture Capital - These transactions mainly depend on our professional assessment of the merits of a typically new or revolutionary idea to be implemented in a major OECD market or the implementation of an established US practice overseas.
Read more
Private Equity -DC&G specializes in private equity transactions in Latin America, with particular emphasis in the Mercosur countries.
Read more
Consulting Mergers and Acquisition - DC&G assists clients in the design and implementation of corporate acquisition and divestiture programs, restructuring and strategic alliances, and a variety of similar non-recurring transactions relating to financial structure and corporate control. Several consulting assignments include debt restructurings and the relationship with local and external creditors
Read more
People
Deals - AIG/CFA - Collectivemind - Confidential - Pharos - TIP - Press
Library - Research and Links. Read more
Contacts - Business - Internships
Spanish
